▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1128 by analyst upside · 2026-11-13
SRZN
Surrozen, Inc.
Healthcare · Market Cap $604M · P/E 0x
ANALYST PRICE TARGET
+100.5%
implied upside to consensus target
Current Price $31.67
Consensus Target $63.5
Bull Target $80.0
Bear Target $54.0
Analysts Covering 4
ANALYST CONSENSUS - BUY
Strong Buy
0
Buy
4
Hold
0
Sell
0
52-Week Low $12.12
52-Week High $37.83
YTD Return +47.0%
FUNDAMENTALS
Market Cap $604M
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-41.94
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $11M
Profit Margin N/A
52-WEEK RANGE
52-Week Low $12.12
52-Week High $37.83
Current Price $31.67
Bear Target $54.0
Bull Target $80.0
● Now $31.67 ● Target $63.5
TRADING DATA
Avg Volume 538K
YTD Return +47.0%
Analyst Count 4
Consensus Buy
Upside to Target +100.5%
Last Updated 2026-11-13

ANALYST SUMMARY

Surrozen, Inc. (SRZN) is currently trading at $31.67 with a Wall Street consensus price target of $63.5, implying potential upside of 100.5% over the next 12 months. 4 analysts currently cover SRZN, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $80.0, while the most cautious has a target of $54.0.

SRZN operates in the Healthcare sector with a market capitalisation of $604M. The stock is up 47.0% year-to-date and is currently trading near the upper end of its 52-week range of $12.12 – $37.83.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for SRZN, with each firm's 90-day track record across all stocks we track. See full firm rankings →

HC Wainwright & Co. - Reiterated
Buy → Buy 2026-09-25 31% win rate (48 calls)
William Blair ● Initiated
Outperform 2026-08-20 44% win rate (9 calls)
HC Wainwright & Co. reit
Buy → Buy 2026-08-10 31% win rate (48 calls)
HC Wainwright & Co. - Reiterated
Buy → Buy 2026-05-07 31% win rate (48 calls)
TD Cowen ● Initiated
Buy 2026-04-21 Building track record
Cantor Fitzgerald reit
Overweight → Overweight 2026-03-24 40% win rate (10 calls)
HC Wainwright & Co. reit
Buy → Buy 2026-03-24 31% win rate (48 calls)
Cantor Fitzgerald ● Initiated
Overweight 2026-02-19 40% win rate (10 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
53
out of 100
Coverage depth
12/30
Consensus clarity
14/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →